LONDON, May 25, 2015 /PRNewswire/ -- Purpose of
Report:
The purpose of this global strategic report is to prepare
executives, company management, and industry investors with the
data and knowledge necessary to make informed, educated decisions
about commercial opportunities within the stem cell biobanking
market.
This global strategic report is produced for:
-Executives of Industrial-Scale Biobanks
-Management of Stem Cell Product Companies
-Management of Stem Cell Therapy Companies
-Biobanking Industry Investors
It is designed to increase your efficiency and effectiveness
in:
1.Effectively pricing stem cell biobanking services
2.Increasing revenue from stem cell biobanking services
3.Identifying new or adjunct stem cell biobanking services to
offer
4.Identifying current market leaders within the stem cell
biobanking market
5.Characterizing the competitive environment for the stem cell
biobanking market
6.Identifying threats and opportunities within the stem cell
biobanking market
7.Acquiring greater market within the stem cell biobanking
market
8.Making intelligent investment decisions within the stem cell
biobanking market
OVERVIEW
Stem cells are primitive cells found in all multi-cellular
organisms that are characterized by self-renewal and the capacity
to differentiate into mature cell types. Stem cells are still
a relatively new discovery, as the first mouse embryonic stem cells
were derived from embryos in 1981, but it was not until 1995 that
the first culturing of embryonic stem cells from non-human primates
occurred. Induced pluripotent stem cells were not produced until
2006. As a result of these discoveries, stem cells can now be
derived at various points during the life cycles.
The following are stages during which stem cells can be
derived:
-Embryonic stem cells, derived from blastocysts
-Fetal stem cells, obtained from fetuses
-Post-natal stem cells derived from newborn tissues, including cord
blood stem cells from umbilical tissue
-Adult stem cells found in adult tissues, including hematopoietic
stem cells, mesenchymal stem cells, and neural stem cells
-Induced pluripotent stem cells, reprogrammed from adult cells
-Cancer stem cells, which give rise to clonal populations of cells
that form tumors or disperse in the body
-And more
Forces Driving the Stem Cell Biobanking Market
Stem cell research and experimentation is largely driven by the
unique ability of stem cells to divide and replicate
repeatedly. In addition, their "unspecialized" nature allows them
to differentiate into a wide variety of specialized cell types. In
a developing embryo, stem cells can differentiate into all of the
specialized embryonic tissues. In adult organisms, stem and
progenitor cells act as a repair system for the body, replenishing
specialized cells.
Therefore, the possibilities arising from these characteristics
have resulted in great commercial interest, with potential
applications ranging from the use of stem cells in reversal and
treatment of disease, to targeted cell therapy, tissue
regeneration, pharmacological testing on cell-specific tissues, and
more. Huntington's disease, Parkinson's disease, and spinal
cord injuries are examples of conditions for which clinical
applications involving stem cells could offer benefits in halting
or even reversing adverse effects.
However, to have stem cells easily accessible for research purposes
and clinical applications requires them to be preserved in stable,
temperature controlled conditions. For this reason, a substantial
market has evolved for the biobanking of tissues containing stem
cell populations and the storage of stem cells themselves.
Stem Cell Biobanking Market
Stem cell biobanking is the cryogenic storage of stem cells, or
biological samples containing stem cells, for later use. The market
for these services is known as the "Stem Cell Biobanking Market."
Because stem cell biobanking often involves the long-term storage
of stem cell samples, the market is sometimes is also known as the
"Stem Cell Storage Market." For purposes of this analysis, these
two terms are considered to be synonymous. A definition of
this market is provided below.
Stem Cell Biobanking Market: The stem cell biobanking market
is defined as the total annual revenue derived from the storage
of:
-Stem cell lines and their derivatives
-All biological samples that were collected specifically because
they contain stem cell populations (e.g. cord blood, adipose
tissue, and more)
This report aims to understand and characterize the competitive
environment for the stem cell biobanking market. As such, the
research is focused on identifying leading participants in the stem
cell storage market, distinguishing their business model, and
exploring their relative market share.
Currently, the four leading providers of biobanking services
are: Fisher Bioservices, Biostorage Technologies, EPL
Archives, and Precision Bioservices. All four companies store
millions of biological samples (15 million by Precision
Bioservices, up to 170 million by Fisher Bioservices) and provide a
diverse set of biobanking services. All but Precision Biosciences
are multi-national companies with both U.S. and European
operations. Because each company has large market share
within the stem cell biobanking market, they are explored
in detail within this report.
However, there are also companies specializing exclusively in stem
cell storage. In one landmark event, Cellular Dynamics
International (CDI) and the Coriell Institute for Medical
Research announced receiving multi-million dollar grants from the
California Institute for Regenerative Medicine (CIRM) for the
creation of induced pluripotent stem cell (iPSC) lines from 3,000
healthy and diseased donors. CIRM awarded CDI $16 million to create three iPSC lines for each
of 3,000 healthy and diseased donors and awarded the Coriell
Institute $10 million to set up and
biobank the iPSC lines. The result will be thecreation of the
world's largest human iPSC bank, an incredible feat.
This iPSC biobank is one example of the expanding market
for stem cell biobanking services. Because the goal of stem cell
biobanking is to create a repository of stem cell specimens –
including source tissue from which stem cells can be derived,
differentiated cell types produced, and disease-specific cell lines
created – large-scale stem cell biobanks provide researchers
with the opportunity to investigate a diverse range of conditions
using stem cells derived from both healthy and diseased
donors. Importantly, biobanks can greatly expand the capacity
for global research and collaboration.
Key report findings include:
-Current Size of the Stem Cell Biobanking Market
-Trailing 5-Year Market Size Data (2011-2015)
-5-year Market Size Projections (2016-2020)
-Market Segmentation
-Market Share by Segment
-Key Industry Leaders
-Detailed Competitive Environment Analysis
-Analysis of Stem Cell Storage Applications (End-Uses)
-Number of Stem Cell Samples Banked, by Industry Leader
-Identification of Opportunities within the Stem Cell
Biobanking Market
-And Much More
Competing within the stem cell biobanking market can involve
complicated and confusing decisions, but it doesn't need to. Claim
this global strategic report to quickly understand current and
future trends within the stem cell biobanking marketplace, identify
opportunities by market segment, and derive more revenue from your
stem cell biobanking products and services.
Download the full report:
https://www.reportbuyer.com/product/2996460/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that
provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/the-market-for-stem-cell-biobanking-and-storage---size-segments-and-trends-300088268.html
SOURCE ReportBuyer